[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @zipjet zipjet zipjet posts on X about $tgtx, subscription, $ual, $1197m the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::23257566/interactions)  - X Week XXXXX -XX% - X Month XXXXXX +11% - X Months XXXXXXX -XX% - X Year XXXXXXXXX +101% ### Mentions: X [#](/creator/twitter::23257566/posts_active)  - X Week XX +18% - X Month XX +38% - X Months XXX -XX% - X Year XXX +102% ### Followers: XXXXX [#](/creator/twitter::23257566/followers)  - X Week XXXXX +0.75% - X Month XXXXX +2.70% - X Months XXXXX +15% - X Year XXXXX +31% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::23257566/influencer_rank)  ### Social Influence [#](/creator/twitter::23257566/influence) --- **Social category influence** [finance](/list/finance) XXXXX% [stocks](/list/stocks) XXXX% [countries](/list/countries) XXXX% **Social topic influence** [$tgtx](/topic/$tgtx) 5.13%, [subscription](/topic/subscription) 2.56%, [$ual](/topic/$ual) 2.56%, [$1197m](/topic/$1197m) 2.56%, [$1036m](/topic/$1036m) 2.56%, [$1byear](/topic/$1byear) 2.56%, [$250mm](/topic/$250mm) 2.56%, [$300mmq](/topic/$300mmq) 2.56%, [$100mm](/topic/$100mm) 2.56%, [fatal](/topic/fatal) XXXX% **Top accounts mentioned or mentioned by** [@martychargin](/creator/undefined) [@ngyojiw](/creator/undefined) [@nomlastew](/creator/undefined) [@aaronrosenblum5](/creator/undefined) [@simonmaechling](/creator/undefined) [@martinvars](/creator/undefined) [@profdbernstein](/creator/undefined) [@stealthqe4](/creator/undefined) [@jhogangidley](/creator/undefined) [@rabbriansamuel](/creator/undefined) [@chrisjustchris9](/creator/undefined) [@theiphawk](/creator/undefined) [@stonefoxcapital](/creator/undefined) [@matthewwielicki](/creator/undefined) [@julianklymochko](/creator/undefined) [@ymdub58](/creator/undefined) [@bittertheblue](/creator/undefined) [@bobkerns](/creator/undefined) [@lammertwijtze](/creator/undefined) [@mpc_xetts](/creator/undefined) **Top assets mentioned** [TG Therapeutics, Inc. (TGTX)](/topic/$tgtx) [United Airlines Holdings, Inc. (UAL)](/topic/$ual) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) ### Top Social Posts [#](/creator/twitter::23257566/posts) --- Top posts by engagements in the last XX hours "Doomberg is a must read for energy investors. (Well worth the subscription.) But todays article on the lunatics running CA and the extraterritorial reach of two new laws arguably hits every large US company. Extract: While the financial risk assessments required by SB XXX should be straightforward enough to comply with the obligations triggered by SB XXX are an entirely different animal. Beginning in 2026 companies will be required to measure and report Scope X and Scope X emissionsthe former defined as a companys direct emissions and the latter as indirect emissions from purchased energy."  [@zipjet](/creator/x/zipjet) on [X](/post/tweet/1947329652357214723) 2025-07-21 16:15:43 UTC 2677 followers, XXX engagements "@simonmaechling The Oxygen is OK but hydrogen gas is explosive"  [@zipjet](/creator/x/zipjet) on [X](/post/tweet/1947826401719021769) 2025-07-23 01:09:37 UTC 2671 followers, XXX engagements "I believe that if a woman were ever in charge of the USA Interesting thought experiment. IF a woman had been in charge of the USA when Hitler came to power . the final solution would have been completed and we would all be speaking German (those of us who were not gassed)"  [@zipjet](/creator/x/zipjet) on [X](/post/tweet/1947388421317497202) 2025-07-21 20:09:15 UTC 2671 followers, XXX engagements "@ngyojiw @nomlastew It is just data. But it is interesting. The more typical formulation is to say the buyout will be 6-12x peak sales when you have long patent protection"  [@zipjet](/creator/x/zipjet) on [X](/post/tweet/1947823913083306346) 2025-07-23 00:59:44 UTC 2666 followers, XXX engagements "$TGTX tables comparing QoQ revenue growth of Briumvi to Kesimpta: IF you can live with XX% to XX% revenue growth and an XX% GM then $TGTX may be for you"  [@zipjet](/creator/x/zipjet) on [X](/post/tweet/1945976714410229899) 2025-07-17 22:39:37 UTC 2670 followers, XXX engagements "Buying $UAL XXXXX to hold into earnings tomorrow"  [@zipjet](/creator/x/zipjet) on [X](/post/tweet/1945171244694855931) 2025-07-15 17:18:58 UTC 2668 followers, XXX engagements "@rabbriansamuel Acts 15:29 21:25. Abstain from Blood Food offered to idols and animals strangled. That seems to allow far greater liberty than the Jewish understanding of the dietary laws"  [@zipjet](/creator/x/zipjet) on [X](/post/tweet/1947463086082036025) 2025-07-22 01:05:56 UTC 2670 followers, XXX engagements "What sales ramp predicts blockbuster drug sales What do we conclude Spanning the nine therapeutic areas we analyzed early revenue milestonestypically $100MM-$300MM/Q by Q4-Q10strongly predict future blockbuster status. Hitting up to $250MM by Q7 was a consistent signal with an 86-100% probability of reaching $1B/year within 3-5 years of launch. $TGTX in Q8 $103.6M Q9 $119.7M Q10 $135M est The accelerator for Briumvi will be a subQ delivery which will roughly double the TAM to $10-12B"  [@zipjet](/creator/x/zipjet) on [X](/post/tweet/1945229138849357974) 2025-07-15 21:09:01 UTC 2674 followers, XXX engagements "$SRPT an AI recap of the 7/18 management presentation: Analysis of Sarepta Therapeutics LGMD Program Update Call This call was convened to address investor concerns and questions arising from the disclosure of a fatal adverse event in a clinical trial for SRP-9004 an investigational gene therapy for LGMD2D and its potential implications for Sarepta's broader gene therapy programs particularly Elevidys. The company aimed to clarify its disclosure strategy the rationale behind discontinuing certain LGMD programs and the impact on Elevidys' safety profile and commercialization strategy. The"  [@zipjet](/creator/x/zipjet) on [X](/post/tweet/1947277777100542062) 2025-07-21 12:49:35 UTC 2670 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
zipjet posts on X about $tgtx, subscription, $ual, $1197m the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence finance XXXXX% stocks XXXX% countries XXXX%
Social topic influence $tgtx 5.13%, subscription 2.56%, $ual 2.56%, $1197m 2.56%, $1036m 2.56%, $1byear 2.56%, $250mm 2.56%, $300mmq 2.56%, $100mm 2.56%, fatal XXXX%
Top accounts mentioned or mentioned by @martychargin @ngyojiw @nomlastew @aaronrosenblum5 @simonmaechling @martinvars @profdbernstein @stealthqe4 @jhogangidley @rabbriansamuel @chrisjustchris9 @theiphawk @stonefoxcapital @matthewwielicki @julianklymochko @ymdub58 @bittertheblue @bobkerns @lammertwijtze @mpc_xetts
Top assets mentioned TG Therapeutics, Inc. (TGTX) United Airlines Holdings, Inc. (UAL) Sarepta Therapeutics, Inc. (SRPT)
Top posts by engagements in the last XX hours
"Doomberg is a must read for energy investors. (Well worth the subscription.) But todays article on the lunatics running CA and the extraterritorial reach of two new laws arguably hits every large US company. Extract: While the financial risk assessments required by SB XXX should be straightforward enough to comply with the obligations triggered by SB XXX are an entirely different animal. Beginning in 2026 companies will be required to measure and report Scope X and Scope X emissionsthe former defined as a companys direct emissions and the latter as indirect emissions from purchased energy." @zipjet on X 2025-07-21 16:15:43 UTC 2677 followers, XXX engagements
"@simonmaechling The Oxygen is OK but hydrogen gas is explosive" @zipjet on X 2025-07-23 01:09:37 UTC 2671 followers, XXX engagements
"I believe that if a woman were ever in charge of the USA Interesting thought experiment. IF a woman had been in charge of the USA when Hitler came to power . the final solution would have been completed and we would all be speaking German (those of us who were not gassed)" @zipjet on X 2025-07-21 20:09:15 UTC 2671 followers, XXX engagements
"@ngyojiw @nomlastew It is just data. But it is interesting. The more typical formulation is to say the buyout will be 6-12x peak sales when you have long patent protection" @zipjet on X 2025-07-23 00:59:44 UTC 2666 followers, XXX engagements
"$TGTX tables comparing QoQ revenue growth of Briumvi to Kesimpta: IF you can live with XX% to XX% revenue growth and an XX% GM then $TGTX may be for you" @zipjet on X 2025-07-17 22:39:37 UTC 2670 followers, XXX engagements
"Buying $UAL XXXXX to hold into earnings tomorrow" @zipjet on X 2025-07-15 17:18:58 UTC 2668 followers, XXX engagements
"@rabbriansamuel Acts 15:29 21:25. Abstain from Blood Food offered to idols and animals strangled. That seems to allow far greater liberty than the Jewish understanding of the dietary laws" @zipjet on X 2025-07-22 01:05:56 UTC 2670 followers, XXX engagements
"What sales ramp predicts blockbuster drug sales What do we conclude Spanning the nine therapeutic areas we analyzed early revenue milestonestypically $100MM-$300MM/Q by Q4-Q10strongly predict future blockbuster status. Hitting up to $250MM by Q7 was a consistent signal with an 86-100% probability of reaching $1B/year within 3-5 years of launch. $TGTX in Q8 $103.6M Q9 $119.7M Q10 $135M est The accelerator for Briumvi will be a subQ delivery which will roughly double the TAM to $10-12B" @zipjet on X 2025-07-15 21:09:01 UTC 2674 followers, XXX engagements
"$SRPT an AI recap of the 7/18 management presentation: Analysis of Sarepta Therapeutics LGMD Program Update Call This call was convened to address investor concerns and questions arising from the disclosure of a fatal adverse event in a clinical trial for SRP-9004 an investigational gene therapy for LGMD2D and its potential implications for Sarepta's broader gene therapy programs particularly Elevidys. The company aimed to clarify its disclosure strategy the rationale behind discontinuing certain LGMD programs and the impact on Elevidys' safety profile and commercialization strategy. The" @zipjet on X 2025-07-21 12:49:35 UTC 2670 followers, XXX engagements
/creator/twitter::zipjet